Alphabet's Verily was one of the company's star "moonshot" businesses, with its research delving into areas ranging from connected diabetes therapies to robot surgery. Now, Verily has shuttered its medical device division and laid off staff, the company announced in a memo seen by Business Insider. The number of employees who lost their jobs was not revealed.<br /> "We have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward," a spokesperson told BI. The cuts are a continuation of Alphabet's 2023 strategic shift that saw the company cut 12,000 positions across multiple divisions while putting more resources toward AI and data infrastructure. <br /> CEO Stephen Gillett hi [...]
Alphabet's life sciences business Verily is restructuring and raising money as a new corporate entity. Verily announced that with its $300 million investment round, it will change from an LLC to [...]
Verily, the health and life sciences subsidiary of Google parent Alphabet, has asked the US Environmental Protection Agency for permission to release up to 64 million lab-bred mosquitoes across Florid [...]
Today, Copenhagen-based healthcare AI Corti is launching Symphony for Speech-to-Text, a new generation of clinical-grade speech recognition models engineered specifically for real-time dictation, conv [...]
Ubisoft is finally releasing The Division Resurgence on March 31 for both iOS and Android. This game was first announced all the way back in 2021 and has suffered from delays in recent years.<br /& [...]
Ex-employees of Annapurna Interactive who quit en masse last year have reportedly found their next project. According to Bloomberg, the team is taking over the games and franchises of Private Division [...]